Universal Ibogaine Inc. (IBO.V)

CAD 0.03

(0.0%)

Gross Profit Summary of Universal Ibogaine Inc.

Universal Ibogaine Inc.'s latest annual gross profit in 2022 was 1.07 Million CAD , down 0.0% from previous year.
Universal Ibogaine Inc.'s latest quarterly gross profit in 2023 Q3 was 428.32 Thousand CAD , up 937.95% from previous quarter.
Universal Ibogaine Inc. reported a annual gross profit of - CAD in annual gross profit 2021, down 0.0% from previous year.
Universal Ibogaine Inc. reported a annual gross profit of - CAD in annual gross profit 2020, down 0.0% from previous year.
Universal Ibogaine Inc. reported a quarterly gross profit of 41.26 Thousand CAD for 2023 Q2, down 0.0% from previous quarter.
Universal Ibogaine Inc. reported a quarterly gross profit of - CAD for 2023 Q1, down -100.0% from previous quarter.

Annual Gross Profit Chart of Universal Ibogaine Inc. (2022 - 2018)

Historical Annual Gross Profit of Universal Ibogaine Inc. (2022 - 2018)

Year	Gross Profit	Gross Profit Growth
2022	1.07 Million CAD	0.0%
2021	- CAD	0.0%
2020	- CAD	0.0%
2019	- CAD	0.0%
2018	- CAD	0.0%

Year	Gross Profit	Gross Profit Growth
2023 Q3	428.32 Thousand CAD	937.95%
2023 Q2	41.26 Thousand CAD	0.0%
2023 Q1	- CAD	-100.0%
2022 Q1	69.8 Thousand CAD	0.0%
2022 FY	1.07 Million CAD	0.0%
2022 Q4	131.2 Thousand CAD	-64.46%
2022 Q3	369.12 Thousand CAD	-14.78%
2022 Q2	433.15 Thousand CAD	520.55%
2021 Q4	- CAD	0.0%
2021 Q2	- CAD	0.0%
2021 Q3	- CAD	0.0%
2021 FY	- CAD	0.0%
2021 Q1	- CAD	0.0%
2020 FY	- CAD	0.0%
2020 Q4	- CAD	0.0%
2020 Q3	- CAD	0.0%
2020 Q2	- CAD	0.0%
2020 Q1	- CAD	0.0%
2019 Q1	- CAD	0.0%
2019 FY	- CAD	0.0%
2019 Q4	- CAD	0.0%
2019 Q3	- CAD	0.0%
2019 Q2	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q4	- CAD	0.0%
2018 Q3	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 Q2	- CAD	0.0%
2017 Q4	- CAD	0.0%

Peer Gross Profit Comparison of Universal Ibogaine Inc.

Name	Gross Profit	Gross Profit Difference
Arch Biopartners Inc.	-128.99 Thousand CAD	930.132%
Covalon Technologies Ltd.	14.36 Million CAD	92.544%
Hemostemix Inc.	-223.00 CAD	480281.166%
Kane Biotech Inc.	109.47 Thousand CAD	-878.171%
MedMira Inc.	-434.91 Thousand CAD	346.212%
Marvel Biosciences Corp.	-887.51 Thousand CAD	220.652%
NervGen Pharma Corp.	-145 Thousand CAD	838.47%
XORTX Therapeutics Inc.	-188.54 Thousand CAD	667.936%